Leukoerythroblastic

Leukoerythroblastic, or leukoerythroblastic reaction, is a hematologic peripheral blood finding in which immature precursors of both white and red blood cells appear in the circulation. Specifically, nucleated red blood cells (erythroblasts) and immature white cell forms such as myelocytes or metamyelocytes are detected on the peripheral smear, often with a left-shifted neutrophil series and sometimes tear-drop red blood cells (dacryocytes). The finding is a qualitative indicator of marrow stress or infiltration rather than a primary blood disorder.

Morphology on the smear typically includes circulating erythroblasts, myelocytes/metamyelocytes, and sometimes promyelocytes, in addition to varying degrees of anisopoikilocytosis. Tear-drop cells may be present, reflecting distorted erythropoiesis. The exact combination can vary between individuals and etiologies.

Causes are usually related to disruption of normal bone marrow architecture or severe marrow stress. Common scenarios include myelophthisis or replacement of marrow by fibrosis, metastatic cancer, granulomatous disease, or other infiltrative processes; severe infections or sepsis; hemorrhage or rapid hematopoietic demand; hypersplenism; and recently cytotoxic therapy or radiation. It can also occur with other conditions that acutely stress the marrow.

Clinical significance lies in its being a non-specific indicator of marrow pathology rather than a diagnosis itself. It prompts evaluation for underlying causes, typically with further testing such as bone marrow biopsy, imaging, and targeted laboratory studies. Management focuses on treating the underlying condition and providing supportive care; prognosis varies with the etiology.